Skip to main content
. Author manuscript; available in PMC: 2019 Apr 18.
Published in final edited form as: Genes Immun. 2018 Jan 8;20(4):308–326. doi: 10.1038/s41435-017-0006-8

Table 4.

Association of HLA-A*02:01 and C*03:04~B*40:01 with Multiple Sclerosis in the presence and absence of DRB1*15:01

Locus Haplotype Controls (N) Patients (N) OR 95% CI Lower 95%CI Upper p-value Significance 1
A~C~B 02:01~03:04~40:01 26 4 0.15 0.04 0.45 6.51E−05 *
A~C~B 02:01~XXXX~XXXX 197 160 0.79 0.62 1.01 4.78E−02 *
A~C~B YYYY~03:04~40:01 24 10 0.42 0.18 0.92 1.82E−02 *
C~B~DRB1 03:04~40:01~WWWW 47 14 0.29 0.15 0.55 2.45E−05 *
C~B~DRB1 ZZZZ~ZZZZ~15:01 85 253 3.95 3.00 5.23 1.24E−25 *
A~DRB1 02:01~15:01 21 56 2.85 1.68 5.01 2.885E−05 *
A~DRB1 02:01~UUUU 202 108 0.48 0.37 0.62 1.13E−08 *
A~DRB1 VVVV~15:01 65 197 3.76 2.77 5.15 1.09E−19 *

UUUU: Any DRB1 allele other than DRB1*15:01

VVVV: Any HLA-A allele other than A*02:01

WWWW: Any DRB1 allele (no C*03:04~B*40:01~DRB1*15:01 haplotypes were observed)

XXXX~XXXX: Any C~B haplotype other than C*03:04~B*04:01

YYYY: Any HLA-A allele other than A*02:01

ZZZZ~ZZZZ: Any C~B haplotype (no C*03:04~B*40:01~DRB1*15:01 haplotypes were observed)

OR: Odds Ratio

CI: Confidence Interval

1

For each locus, the evaluation of significance was informed by the significance of locus-level heterogeneity as shown in Table 1. P-values were not corrected for loci that displayed significant locus-level heterogeneity. Significant p-values are indicated with asterisks.